Unyango lwe-antiretroviral

Intsholongwane kaGawulayo kunye noGawulayo zizifo ezingenakuphulukiswa, kodwa ukunyuka kwazo kunganciphisa ngokufumana ixesha elizeleyo lokufumana amachiza akhethekileyo. Ulwaphulo lwe-antiretroviral olubandakanya ukusetyenziswa kwezilwanyana ezintathu okanye ezine kuxhomekeke kwisigaba sesifo kunye nomyinge ochazwe ngugqirha.

Usebenza njani unyango lwe-antiretroviral?

I-virus yokugonywa kwe-immunodeficiency ine-high mutagenicity. Oku kuthetha ukuba kunzima kakhulu kwimiphumo eyahlukeneyo kwaye uyakwazi ukutshintsha i-RNA yayo, ukudala utshintsho olutsha olunokwenzeka. Le propati iyanzima kakhulu unyango lwe-HIV kunye ne-AIDS, njengoko iiseli ze-pathogenic zilungelelanisa ngokukhawuleza kwiziyobisi ezithathwe.

Ulwaphulo lwe-antiretroviral ludibanisa imithi e-3-4 eyahlukeneyo, nganye leyo inemigaqo ekhethekileyo yokwenza. Ngaloo ndlela, ukuthatha izidakamizwa ezininzi kunikezela ukuxhatshazwa kweyona nto ingundoqo yintsholongwane, kodwa kwanoma yiyiphi enye inguquko yayo eyenziwe ngexesha lophuhliso lwesifo.

Uphi unyango oluchazwe ngama-antiretroviral?

Ngokuqhelekileyo, kwangaphambili unyango lwe-HIV luqala, kuya kuba ngcono ukuyeka ukunyuka kwegciwane, ukuphucula umgangatho kunye nokuphila kweso sigulane. Ngenxa yokuba iimpawu zokuqala zesifo zihlala zingabonwa, unyango lwe-antiretroviral lusekwe malunga neminyaka emi-5-6 emva kokusuleleka, kwiimeko ezinqabileyo eli xesha liye landa ukuya kwiminyaka eyi-10.

Iidakamizwa zonyango olukhutheleyo lwe-antiretroviral

Amachiza ahlukeneyo kwiiklasi:

1. Inhibitors ye-reverse transcriptase (i-nucleoside):

2. I-non-nucleoside reverse transcriptase inhibitors:

3. Iprotease inhibitors:

Ama-inhibitors of fusion ayingcali etsha kunayo yonke yezilwanyana kwi-antiretroviral. Okwangoku kuphela isicatshulwa esisodwa esaziwa yi-Fuzeon okanye i-Enfuvirtide.

Imiphumo emibi yeyeza-antiretroviral

Imiphumo engeyona ingozi:

Imiphumo emibi: